Just The News

FDA warns of issues with MR-guided laser interstitial thermal therapy devices

8 hours ago

The FDA today released a safety alert warning of issues with magnetic resonance-guided laser interstitial thermal therapy devices that could result in tissue overheating. In its warning, the FDA said that it is “evaluating data” that suggest potentially inaccurate MR thermometry information could be displayed during treatment, which could contribute to potential errors in ablation […]

The post FDA warns of issues with MR-guided laser interstitial thermal therapy devices appeared first on MassDevice.

Following first profitable quarter, Vericel’s CEO looks to grow portfolio of autologous cell therapy products

8 hours ago

In its latest financial results, Cambridge, Mass.-based Vericel (NSDQ:VCEL) saw sales climb 60% for its permanent skin-replacement product, Epicel, designed for patients with severe burns. Sales for its autologous cellular scaffold, Maci, were up 20% following its launch to the commercial market. Vericel’s growing product adoption helped to fuel the company’s first profitable quarter, according to CEO […]

The post Following first profitable quarter, Vericel’s CEO looks to grow portfolio of autologous cell therapy products appeared first on MassDevice.

Report: J&J’s Cerenovus to discontinue Codman liver cancer pump

8 hours ago

Johnson & Johnson‘s (NYSE:JNJ) Cerenovus is discontinuing production of Codman pumps designed to deliver targeted chemotherapy to the liver for patients with liver cancer, according to a New York Times report. The devices are designed to be implanted in the abdomen to deliver chemotherapy directly to the liver to treat cancer that has spread to […]

The post Report: J&J’s Cerenovus to discontinue Codman liver cancer pump appeared first on MassDevice.

Medtronic touts two-year Harmony transcath pulmonary valve feasibility study data

9 hours ago

Medtronic (NYSE:MDT) today released two-year outcomes from an early feasibility study of its Harmony transcatheter pulmonary valve, touting solid valve function no reports of paravalvular leaks. Results were presented at the Society for Cardiovascular Angiography and Interventions 41st annual scientific sessions, the Fridley, Minn.-based company said. “Following the one-year feasibility outcomes, we are encouraged to see […]

The post Medtronic touts two-year Harmony transcath pulmonary valve feasibility study data appeared first on MassDevice.

Purpose-Built Smartphones for Healthcare: Interview with Andrew Duncan, VP at Spectralink

10 hours ago

Spectralink, an enterprise mobile communications provider based in Colorado, aims to enhance patient care, clinician productivity, and workflow efficiency for hospitals worldwide with purpose-built clinical communications solutions. The company provides specialty-built smartphones for healthcare staff. Their devices have been designed with the healthcare environment, and its unique challenges and requirements, in mind. Spectralink claims that […]

Report: Johnson & Johnson wins appeal in $151m hip verdict

10 hours ago

Johnson & Johnson (NYSE:JNJ) yesterday won an appeal in a ruling that had previously awarded $151 million to five individuals who claimed they had injuries due to company’s Pinnacle metal-on-metal hip implant, according to a new Reuters report. The ruling came down from the 5th US Circuit Court of Appeals, which said that the defective marketing […]

The post Report: Johnson & Johnson wins appeal in $151m hip verdict appeared first on MassDevice.

Zika virus wipes out two types of brain tumors in mice

12 hours ago

Some cancer researchers see potential in exploiting the Zika virus' ability to infect the brain. Among them is a team at the University of São Paulo in Brazil, which is reporting promising results after testing a low concentration of purified Zika virus in mice with medulloblastoma and atypical teratoid rhabdoid tumor.

Zika virus wipes out two types of brain tumors in mice

12 hours ago

Some cancer researchers see potential in exploiting the Zika virus' ability to infect the brain. Among them is a team at the University of São Paulo in Brazil, which is reporting promising results after testing a low concentration of purified Zika virus in mice with medulloblastoma and atypical teratoid rhabdoid tumor.

Medineering touts first uses of Robotic Endoscopy system

12 hours ago

German robotic surgical start-up Medineering said today its Medineering Robotic Endoscopy system was used in its first clinical procedures after having won CE Mark approval in the European Union last year. The company said that the robotic endoscopic system has been used in several clinical settings in university hospitals across Germany and Italy. The Robotic Endoscopy system […]

The post Medineering touts first uses of Robotic Endoscopy system appeared first on MassDevice.

Students Design Specialty Bag for Treating Children Born with Gastroschisis

12 hours ago

Gastroschisis is a birth defect in which some of the baby’s intestines end up outside the body, protruding through a ventral opening near the navel. In developed countries this is a treatable condition that typically requires a series of surgeries and a special bag that holds the intestines in a sterile environment while they slowly […]

Restech acquires Mederi Medical

12 hours ago

Medtech developer Respiratory Technology Corp said today it acquired Mederi Therapeutics, and its Stretta catheter and Secca system, for an undisclosed amount. Houston-based Restech said that the addition of the Stretta catheter, designed to treat gastroesophageal reflux disease, and the Secca system, designed to treat bowel incontinence, are complimentary to its existing diagnostic devices. Mederi’s […]

The post Restech acquires Mederi Medical appeared first on MassDevice.

Hep C and Humira lead AbbVie's Q1 revenue growth

13 hours ago

AbbVie posted better than expected Q1 earnings this morning, led by HUMIRA, IMBRUVICA and their Hepatitis C franchise. Total worldwide revenue was $7.934 billion, helping AbbVie achieve YOY growth of 17.4% in the quarter. 

AbbVie's heavily weighted revenue from HUMIRA is concerning and yet impressive, considering 2/3 of the companies revenue comes from the product. Where the concern lessens is from the continued growth in HCV, where their franchise exploded to $919 million in revenue, easily outpacing consensus estimates of ~$4 billion.

NuProbe Global to Commercialize Multiplexed, Rare Gene Testing Technology

13 hours ago

Harvard’s Wyss Institute researchers are bringing a specific and multiplexed genetic diagnostic technology to market with NuProbe Global, a Boston based company. It addresses the current need to detect rare genetic mutations, which may be present in only a few cells of the body. Current detection techniques using gene amplification are not specific enough and […]

ConMed shares rise on beat-and-raise Q1

13 hours ago

Shares in ConMed (NSDQ:CNMD) have risen today after the medical device maker beat expectations on Wall Street with its first quarter earnings results. The Utica, N.Y.-based company posted profits of $10.7 million, or 37¢ per share, on sales of $202.1 million for the three months ended March 31, seeing a swing from red ink on the […]

The post ConMed shares rise on beat-and-raise Q1 appeared first on MassDevice.

Tiny Wireless Optical Implant for Neural Control

13 hours ago

Researchers in Japan have developed a tiny optical implant, no bigger than the width of a coin, that could be used to change neural behavior. The researchers can implant the device several centimeters into the body, and then activate it externally using infrared light. The device could make it easier for researchers to identify the […]

InVivo Therapeutics registers $8m offering

14 hours ago

InVivo Therapeutics (NSDQ:NVIV) today registered for an upcoming offering, looking to raise approximately $8 million, according to an SEC filing. In the offering, the Cambridge, Mass.-based company will look to offer shares of common stock and Series A warrants. The offering is slated to include a 45-day underwriter’s option for the purchase of additional shares, according […]

The post InVivo Therapeutics registers $8m offering appeared first on MassDevice.

Align Tech shares rise on Street-beating Q1, iTero CFDA win, product launches

14 hours ago

Shares in Align Technology (NSDQ:ALGN) rose today after the dental-focused device maker posted Street-beating Q1 earnings alongside a number of other updates, including a clearance from China’s FDA, an update on a legal spat with SmileDirectClub and multiple product launches. The San Jose, Calif.-based company posted profits of $95.9 million, or $1.17 per share, on sales of […]

The post Align Tech shares rise on Street-beating Q1, iTero CFDA win, product launches appeared first on MassDevice.

V-Wave closes $70 million Series C

15 hours ago

V-Wave said today it raised $70 million in a closed Series C round of financing, with funds slated to support the launch of a pivotal trial of its investigational interatrial shunt device designed for patients with advanced heart failure. The interatrial shunt is designed to be implanted trans-venously and placed in the atrial septum, the Israel-based company said. […]

The post V-Wave closes $70 million Series C appeared first on MassDevice.

Cardiac Dimensions anchors $39m Series B for Carillon mitral repair device

16 hours ago

Cardiac Dimensions said today that it raised a $39 million Series B round for the Carillon mitral valve repair device it’s developing. Kirkland, Wash.-based Cardiac Dimensions said the round was led by a new Australian backer, Hostplus, and included a venture debt contribution from Oxford Finance. Existing investors M. H. Carnegie, Arboretum Ventures, Lumira Capital, LSP Health […]

The post Cardiac Dimensions anchors $39m Series B for Carillon mitral repair device appeared first on MassDevice.

Baxter beats The Street with Q1 results

16 hours ago

Shares in Baxter (NYSE:BAX) rose today in pre-market activity after the medical device maker beat expectations on Wall Street with its first-quarter results. The Deerfield, Ill.-based company posted profits of $389 million, or 71¢ per share, on sales of $2.68 billion for the 3 months ended March 31, for bottom-line growth of 43% on sales growth of […]

The post Baxter beats The Street with Q1 results appeared first on MassDevice.

Zimmer Biomet’s Q1 beats The Street despite profit slide

16 hours ago

Zimmer Biomet (NYSE:ZBH) beat both the consensus forecast and its own guidance with its first-quarter results despite a more than 40% profit slide. The Warsaw, Ind.-based orthopedics giant posted profits of $174.7 million, or 85¢ per share, on sales of $2.02 billion for the three months ended March 31, for a bottom-line slide of -41.6% on […]

The post Zimmer Biomet’s Q1 beats The Street despite profit slide appeared first on MassDevice.

Twice rejected by Lilly, Adocia mounts recovery with diabetes drug deal

16 hours ago

Adocia has sold the Chinese rights to two diabetes prospects to Tonghua Dongbao Pharmaceuticals for $50 million (€41 million) upfront. The deal sparked a 30% jump in Adocia’s stock price as investors cheered evidence the biotech is gaining momentum 15 months after being dumped by Eli Lilly.

Twice rejected by Lilly, Adocia mounts recovery with diabetes drug deal

16 hours ago

Adocia has sold the Chinese rights to two diabetes prospects to Tonghua Dongbao Pharmaceuticals for $50 million (€41 million) upfront. The deal sparked a 30% jump in Adocia’s stock price as investors cheered evidence the biotech is gaining momentum 15 months after being dumped by Eli Lilly.

Novocure misses sales, EPS estimates in Q1

16 hours ago

Shares in Novocure (NSDQ:NVCR) fell today after the medical device maker missed expectations on Wall Street with its first-quarter results. The St. Helier, N.J.-based company posted a net loss of -$20.7 million, or -23¢ per share, on sales of $52.1 million for the 3 months ended March 31, for bottom-line loss of -14.8% on sales growth of […]

The post Novocure misses sales, EPS estimates in Q1 appeared first on MassDevice.

MicroPort Scientific buys Lombard Medical out of bankruptcy

17 hours ago

Lombard Medical Technologies (NSDQ:EVAR) said today that it was acquired out of bankruptcy by MicroPort Scientific (HK:00853), which hopes to get Lombard’s stent grafts on the market in China. MicroPort put $15 million into Lombard back in December 2016 in a deal that aimed to accelerate the commercialization of Lombard’s Aorfix and Altura stent grafts for treating abdominal […]

The post MicroPort Scientific buys Lombard Medical out of bankruptcy appeared first on MassDevice.

Brain Power Has Created A Novel Google Glass Autism App (Interview)

18 hours ago

The month of April is Autism Month. Autism affects 3.5 million families in the United States alone, with each person uniquely on the spectrum. These people commonly experience symptoms related to attention-deficit/hyperactivity disorder (ADHD), including hyperactivity, inattention, and impulsivity, but more well known is their struggle to decode emotions, to manage transitions and behaviors, eye […]

FDA Approves Test for Spontaneous Preterm Birth

1 day ago

QIAGEN won FDA’s OK to introduce its PartoSure test for estimating the risk of spontaneous preterm birth to be used for women that are experiencing symptoms of preterm labor. The test identifies the presence of placental alpha microglobulin-1 (PAMG-1), a pretty good indicator that the fetal membrane has suffered a break. The test has already been […]

Printing Functional Electronics Directly Onto Skin

1 day ago

University of Minnesota researchers have figured out a way of printing electronics on top of skin, even onto hands that are unrestrained and slightly moving. We got a peek at the technology in the Fall of last year, when it was first presented at the 2017 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) in […]

Varian Medical Q2 beats The Street

1 day ago

Shares in Varian Medical (NYSE:VAR) have risen slightly today in after hours trading after the medical device maker posted fiscal year 2018 second quarter earnings that beat The Street and saw profits and sales grow. The Palo Alto, Calif.-based company posted profits of $73.2 million, or 79¢ per share, on sales of $729.9 million for the […]

The post Varian Medical Q2 beats The Street appeared first on MassDevice.

Merit Medical Q1 earnings beat The Street, despite shrinking profits

1 day ago

Shares in Merit Medical (NSDQ:MMSI) have risen slightly today in after hours trading after the medical device maker posted first quarter earnings that beat consensus on Wall Street but saw profits shrink over 50%. The South Jordan, Utah-based company posted profits of $5.3 million, or 10¢ per share, on sales of $203 million for the three […]

The post Merit Medical Q1 earnings beat The Street, despite shrinking profits appeared first on MassDevice.

CAR-T 2.0? A split, universal and programmable system

1 day ago

Recent FDA approvals have validated the use of chimeric antigen receptor T cells (CAR-Ts) to fight blood cancers, but the technology is still far from perfect. A Boston University team has devised what they call the "Swiss army knife" of CAR-T to address problems with current CAR-T systems and potentially apply them to more tumor types.

CAR-T 2.0? A split, universal and programmable system

1 day ago

Recent FDA approvals have validated the use of chimeric antigen receptor T cells (CAR-Ts) to fight blood cancers, but the technology is still far from perfect. A Boston University team has devised what they call the "Swiss army knife" of CAR-T to address problems with current CAR-T systems and potentially apply them to more tumor types.

Medin Technologies taps Donaldson as CEO | Personnel Moves – April 25, 2017

1 day ago

Medin Technologies said last week it tapped Bill Donaldson as its new chief executive officer, replacing Andy Novotny who is resigning from his position at the head of the company. Prior to joining Medin Technologies, Donaldson served as president of Jeld-Wen Canada, leading the business unit during its parent company’s initial public offering, Totowa, N.J.-based […]

The post Medin Technologies taps Donaldson as CEO | Personnel Moves – April 25, 2017 appeared first on MassDevice.

This is not your parents’ FDA

1 day ago

Medtech veterans have come to expect the path to regulatory approval to be arduous or even painful one. As the pace of development accelerated, it seemed that the FDA couldn’t – or wouldn’t – keep up. But in recent years, the federal safety watchdog adapted, becoming more responsive and transparent, according to Boston Scientific (NYSE:BSX) regulatory […]

The post This is not your parents’ FDA appeared first on MassDevice.

Shockwave’s S4 Catheter Shakes Calcified Plaque Off Peripheral Arteries

1 day ago

Shockwave Medical, out of Freemont California, won European regulatory approval to introduce its Shockwave S4 Peripheral Intravascular Lithotripsy Catheter. The catheter can be used to work on arteries below the knees, shocking them with ultrasound to displace plaque compacted to the vessel walls. The frequency of the ultrasound is tuned to the resonant frequency of […]

Natus Medical Q1 results beat The Street despite swing to red ink

1 day ago

Shares in Natus Medical (Nasdaq: BABY) fell today after the newborn-focused medical device maker posted first quarter earnings that saw profits turn to losses, despite topping Wall Street expectations for sales and earnings per share. The Pleasanton, Calif.-based company posted losses of approximately $3.2 million, or 10¢ per share, on sales of $128.6 million for the three […]

The post Natus Medical Q1 results beat The Street despite swing to red ink appeared first on MassDevice.

Diversified growth lifts Boston Scientific in Q1

1 day ago

Boston Scientific reported 2018 Q1 earnings this morning, posting sales of $2.379 billion, growing operationally 10.1% with organic growth of 5.2%, compared to prior year growth in the same quarter. Additionally, the company raised FY 2018 guidance, now

Device Keeps Implanted Pancreatic Islets Oxygenated and Alive

1 day ago

MIT researchers have developed a device to keep implanted pancreatic islets oxygenated and alive. The technique involves a replenishable oxygen reservoir and a coating that protects the cells from the immune system. In tests in diabetic rats, the subcutaneous implants kept nearly 90% of the islets alive for up to eight months, and blood glucose […]

How 3D printed cells on the skin could enable wound healing

2 days ago

Researchers at the University of Minnesota are 3D printing electronics and cells directly on the skin that could create new methods for wound healing and enable biological agent detection. The Minnesota researchers used a customized, low-cost 3D printer to print electronics on a human hand. They’ve also successfully printed biological cells on a sin wound of […]

The post How 3D printed cells on the skin could enable wound healing appeared first on MassDevice.

Wearable Non-Invasively Assesses Tendon Tension During Physical Activity

2 days ago

Researchers at the University of Wisconsin-Madison have developed a wearable device that can non-invasively measure tendon tension when wearers are engaged in physical activity. The technology could help researchers to measure and understand the forces that act on muscles during movement. These data are useful for scientists designing treatments and prostheses for patients with gait […]

Hologic wins FDA PMA for ThinPrep automated Pap test imager

2 days ago

Hologic (NSDQ:HOLX) said today it won FDA premarket approval for its ThinPrep integrated imager designed for the automated imaging of Pap tests. The Marlborough, Mass.-based company’s ThinPrep imager is designed to aid cytology technicians in identifying abnormal cells, and combines an imaging station and review scope into a single unit. The system takes approximately 90 seconds […]

The post Hologic wins FDA PMA for ThinPrep automated Pap test imager appeared first on MassDevice.

Terumo Releases a Narrower Stent-Graft for TEVAR Procedures

2 days ago

Terumo is launching in Europe its RelayPro Thoracic Stent-Graft System, initially being released to a limited set of institutions with wider availability expected soon. The device is designed to allow patients with narrower access vessels to benefit from thoracic endovascular aortic repair (TEVAR) procedures. It’s based on the previously available RelayPlus, but with an outer diameter […]

Theravance Biopharma touts expanded FDA nod for GSK’s Trelegy Ellipta inhaler

2 days ago

Theravance Biopharma‘s (NSDQ:TBPH) said today that the FDA granted expanded indications for GlaxoSmithKline‘s (NYSE:GSK) Trelegy Ellipta inhaler, now approved for use to treat a broader population of chronic obstructive pulmonary disease patients. With the expansion, the inhaler is now cleared for COPD patients with airflow limitations and for those who have experienced an acute worsening of […]

The post Theravance Biopharma touts expanded FDA nod for GSK’s Trelegy Ellipta inhaler appeared first on MassDevice.

Abiomed shares down on proposed CMS reimbursement change

2 days ago

Abiomed (NSDQ:ABMD) shares have fallen slightly today after the Centers for Medicare and Medicaid Services released a proposal covering changes in its reimbursement. The proposed rule would result in an approximately 24% cut to the reimbursement rates for certain procedures with its Impella heart pump, according to a Leerink Partners report. “This rate cut may ultimately […]

The post Abiomed shares down on proposed CMS reimbursement change appeared first on MassDevice.

What's your Aimovig rollout plan, Amgen? Growth-hungry investors want to know

2 days ago

Amgen’s migraine drug Aimovig isn’t even approved by the FDA yet, but questions about its insurance coverage overshadowed the company’s better-than-expected quarterly earnings. One reason why, perhaps? Pharmacy benefits manager Express Scripts is urging the company to rethink its expected $8,000 to $10,000 list price.

Shire and Takeda come to terms with a $64B deal, the biggest pharma M&A in years

2 days ago

We have a deal—at least a preliminary one. Late Tuesday, Shire said Takeda had finally landed on a buyout offer worth recommending to shareholders. Namely, £49 per share, about 44% of that in cash. Takeda shareholders weren't exactly thrilled, though. The Japanese drugmaker's shares dropped 7% Wednesday morning.

Daiichi DMD trial misses primary efficacy endpoint

2 days ago

An early-phase trial of Daiichi Sankyo’s Duchenne muscular dystrophy (DMD) drug has failed to show clear evidence of efficacy. But, buoyed by safety data and evidence of exon-skipping activity, Daiichi is pushing ahead with further development of the antisense oligonucleotide.

Daiichi DMD trial misses primary efficacy endpoint

2 days ago

An early-phase trial of Daiichi Sankyo’s Duchenne muscular dystrophy (DMD) drug has failed to show clear evidence of efficacy. But, buoyed by safety data and evidence of exon-skipping activity, Daiichi is pushing ahead with further development of the antisense oligonucleotide.

Pernix and company ink $75M deal to put Orexigen out of its misery

3 days ago

It’s been a painful few years for Orexigen Therapeutics in the obesity arena, and the company is finally ready to bow out. The San Diego-based drugmaker has inked a pact with Nalpropion Pharmaceuticals—a new company funded in part by specialty drugmaker Pernix Therapeutics—to sell worldwide rights to obesity med Contrave and other assets for $75 million in cash.

Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib

3 days ago

It's been a good news-bad news 24 hours for Eli Lilly. Its closely watched RA prospect baricitinib didn't exactly sail through Monday's FDA committee meeting. But Tuesday morning, Lilly rolled out first-quarter results that beat sales and earnings expectations. Upshot? Analysts are still worried about a baricitinib approval.

Philips posts solid start to 2018

3 days ago

Philips released Q1 earnings this morning and posted solid results to start off 2018.Sales in the quarter were EUR 3.9 billion, with comparable sales growth of 5% Comparable order intake increased 10% compared to Q1 2017

FDA still not happy with Kamada inhaled AAT drug

4 days ago

Israeli biotech Kamada has hit another hurdle in its marathon bid to bring the first inhaled treatment for alpha-1 antitrypsin (AAT) deficiency to market as an alternative to intravenous drugs.

FDA still not happy with Kamada inhaled AAT drug

4 days ago

Israeli biotech Kamada has hit another hurdle in its marathon bid to bring the first inhaled treatment for alpha-1 antitrypsin (AAT) deficiency to market as an alternative to intravenous drugs.

Pfizer's first U.K. ads for OTC Viagra put erectile dysfunction in perspective

4 days ago

Pfizer’s first ad campaign for over-the-counter Viagra in the U.K. uses comparisons to illustrate the relative commonplace incidence of erectile dysfunction. Print and out-of-home ads begin with the fact that “4.3 million men in the U.K. experience erectile problems.” The text-heavy ads then note comparisons such as, “That’s more men than there are cabs in the whole of the U.K.” or “That’s enough men to fill every major British football stadium.”

Sanofi diabetes research chief takes CSO post at Grünenthal

4 days ago

Sanofi is set to lose its global head of diabetes research and translational medicine to Grünenthal. Philip Just Larsen, M.D., Ph.D., will join the German pain specialist at the start of July, leaving Sanofi looking for a diabetes research chief and CSO for its Frankfurt hub.

Sanofi diabetes research chief takes CSO post at Grünenthal

4 days ago

Sanofi is set to lose its global head of diabetes research and translational medicine to Grünenthal. Philip Just Larsen, M.D., Ph.D., will join the German pain specialist at the start of July, leaving Sanofi looking for a diabetes research chief and CSO for its Frankfurt hub.

Boehringer Ingelheim expands adherence-improving respiratory rewards program

4 days ago

​​​​​​​The word "gamification" gets tossed around a lot in marketing and loyalty programs, but for Boehringer Ingelheim it’s more than just a buzzword. The pharma company recently expanded its RespiPoints online rewards program because it works. Today, four of its respiratory drugs to treat COPD and asthma are in the program, run in conjunction with HealthPrize Technologies.

Gene editing shows promise in combating HIV reservoirs

7 days ago

Gene therapy has experienced a renaissance of late, and it’s a technology that many researchers in HIV are embracing. That's because the ability to manipulate genes—particularly CCR5, which is known to play a role in HIV resistance—could help eliminate dormant reservoirs of virus that can resurge at any time.

Gene editing shows promise in combating HIV reservoirs

7 days ago

Gene therapy has experienced a renaissance of late, and it’s a technology that many researchers in HIV are embracing. That's because the ability to manipulate genes—particularly CCR5, which is known to play a role in HIV resistance—could help eliminate dormant reservoirs of virus that can resurge at any time.

Mazor Robotics Q1 2018 Investor Presentation

1 week ago

The following Q1 2018 investor presentation was published by Mazor Robotics. Mazor is expected to release earnings on or before May 9, 2018. We will be covering their earnings release.

Boston Scientific Acquires nVision Medical

1 week ago

Boston Scientific announced the acquisition of nVision Medical, who developed the first and only device cleared by the U.S. Food and Drug Administration to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of

J&J Vision Announces Revolutionary Transitional Contact Lens

2 weeks ago

Johnson & Johnson Vision just announced one of the more exciting new contact lens products to hit the market in years. They partnered with Transition Optical, the leading provider of photochromic (smart adaptive) lenses and came up with the ACUVUE OASYS

Intersect ENT commercially launches SINUVA sinus implant

3 weeks ago

Intersect ENT announced the commercial availability of their long-awaited SINUVA Sinus Implant yesterday. The SINUVA Sinus Implant provides a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.

Abbott invests in diabetes startup Bigfoot Biomedical

4 weeks ago

One of the more ambitious and interesting early stage medtech companies, Bigfoot Biomedical, announced the final close of their Series B, bringing in $55 million, including an undisclosed investment from Abbott. The total funding to date is more than $90

Boston Scientific Acquires NxThera for $406 Million

1 month ago

The rumors have been discussed for two years that Boston Scientific would acquire NxThera, the developer of Rezum, a minimally invasive therapy that treats BPH (benign prostatic hyperplasia). Today Boston Scientific made it official, acquiring NxThera

TransEnterix Earnings: What Did We Learn?

2 months ago

During their most recent earnings call, TransEnterix shared some notable highlights in regards to their cash position, expanded indications and the sale of two Senhance systems thus far in Q1 of 2018.

Apple opening AC Wellness clinics for employees and their families

2 months ago

In the fall of 2017, it was reported that Apple was deep in discussions to acquire Crossover Health, who ran Apple's on-site medical clinic. For undisclosed reasons, the deal never materialized, and as reported by CNBC, Apple recently started letting

What will Amazon's impact be on the medical supply business?

2 months ago

It was recently reported that Amazon is getting into the healthcare business via a partnership with JPMorgan and Berkshire Hathaway where they will create a healthcare company for their own employees. Now it appears Amazon is also looking to disrupt

Introducing the Medtech[y] Medical Sales Job Board

3 months ago

Today we are launching the new Medtech[y] Job Board. Since the start, our goal has been to launch a medical sales job board that gives job seekers and employers an easy way to connect, and we think we’ve built that solution.

Amazon looks to disrupt the game of healthcare

3 months ago

From a partnership with Patterson Dental to selling medical supplies and pharmaceuticals, the rumors of Amazon getting into the healthcare game have been going on for several years.

Why Doesn't MiMedx Report Open Payments Data?

3 months ago

We recently wrote about Marc Cohodes questioning MiMedx CEO, Parker Petit, at the JP Morgan Healthcare Conference earlier this month. Since the meeting, both MiMedx and Marc Cohodes have defended their positions via Twitter and websites that

3 sales tips to get off to a fast start in 2018

4 months ago

The new year always comes with lofty goals, which typically start with unused gym memberships and unproductive quarterly planning meetings. They should be useful, but many times we end up going through the motions and write out unachievable goals that

Stryker Layoffs [Thread]

4 months ago

We recently received an anonymous tip regarding layoffs and compliance issues at Stryker

Allergan Layoffs [Thread]

4 months ago

Allergan announced that it plans to cut more than 1,000 jobs as it braces for one of its bestselling drugs to face generic competition.

The Top 10 Medtechy Articles From 2017

4 months ago

Over the course of 2017, the visitors to our anonymous message boards increased as the word continued to get out about Medtechy. We have a mixed viewership of employees in the medical sales industry and investors interested in biotech and medical device.

Has Titan Medical missed their opportunity with SPORT?

4 months ago

As a medical device rep, and a once proud owner of Titan Medical stock, I am genuinely disappointed in this company because I believe they have a solid product in SPORT. The question, though, is how much longer will it be considered a solid product?

Can Instagram Be MannKind Afrezza's Best Marketing Tool?

5 months ago

Can Instagram be the pharmaceutical industry's new best friend? This post is by no means a case study, but there are certain sets of patients who actively seek out better treatment options, and patients with Diabetes are at the top of this unscientific

Medtronic and Mazor Robotics Need Each Other

6 months ago

Let's just get this out of the way: Mazor wants to grow and Medtronic needs to infuse growth into their Spine business. In other words, an acquisition does not need to happen in order for this relationship to work.

What's Next for TransEnterix after Senhance's FDA Clearance

6 months ago

In typical FDA fashion, TransEnterix received their FDA clearance letter late Friday afternoon for their Senhance surgical robot which was very welcomed by investors as the stock jumped 63% in after-hours trading. Senhance is the first new entrant into

Business Travel Tip: Watch your home TV with a streaming stick

6 months ago

Your family thinks those weekly business trips are filled with dinner at the best restaurants and stays at 5-star hotels, but we, the road warriors, know it's quite the opposite. For most of us, the most expensive meal we get is from an Outback

TransEnterix is one step closer to FDA approval for Senhance

7 months ago

With the recent stock run-up, and the year coming to a close, any TRXC investor with a pulse has seen this coming for a while now. This morning, TransEnterix announced they've submitted their AI response to the FDA, setting the stage for a

NEA Backed NeoTract Acquired by Teleflex

8 months ago

Serial entrepreneur and NEA General Partner, Josh Makower, hit another home run today when Teleflex acquired NeoTract, the company he co-founded with Ted Lamson.

MedReps 2017 Medical Sales Salary Report

11 months ago

MedReps recently released their seventh annual medical sales salary report and the information for prospective medical sales representatives continues to be invaluable.

Stryker Sues Biomet for Stealing Reps and Corporate Secrets

1 year ago

Stryker (Howmedica Osteonics Corp) takes their non-compete agreements seriously, and on Wednesday, they sued three Biomet affiliates in Texas, claiming they poached Stryker employees involved in the Foot and Ankle business.

Are you a new manager? Start with this simple book

1 year ago

So you finally got your first management job! Congrats! Don't get too used to those words, though. You won't hear them too often from this point on. Wait, you got into management for the fame and recognition? Whoops...wrong career decision if that's what

Arguments begin in appeal of ex-Stryker rep’s $750k loss

1 year ago

The oral arguments began today for the appeal of a $750,000 loss an ex-Stryker rep incurred in a lawsuit over his move to Stryker's competitor, Biomet. As previously reported, Stryker sued ex-sales reps, Chris Ridgeway and Richard Steitzer, in September

MedReps' 2017 Best Places to Work in Medical Sales

1 year ago

MedReps surveyed over 1,200 community members in order to come up with the winners and some of the biggest and well know medical sales companies came out on top. The overall winners went to: Medtronic, Johnson & Johnson and Stryker.

Three tips to whip your sales territory into shape in the new year

1 year ago

The new year always comes with lofty goals, which typically start with unused gym memberships and unproductive quarterly planning meetings. They should be useful, but many times we end up going through the motions and write out unachievable goals that

4 Ways to Improve Your Strategic Thinking Skills

1 year ago

If you’ve ever received feedback that you “need to be more strategic,” you know how frustrating it can feel. To add insult to injury, the feedback rarely comes with any concrete guidance on what to do about it.

Boost sales with a simple 7 step pre-call plan

1 year ago

Pre-call plans are one of the most effective tools a sales rep can use in preparing for a sales call. However, in our experience, sales reps bypass using them unless they happen to be on a field ride with their manager.

What is medtechy and how can it benefit medical sales reps?

1 year ago

Isn't Medtechy just Cafepharma for the medical device industry? The answer is no, but we've heard that question before. We understand the similarities as both sites have anonymous messages boards for pharmaceutical and medical device companies. However, a

The Medtech[y] Minute

1 year ago

It's been a busy week on the boards and our new blog, The Ticker, so we thought it would be helpful to round up the most popular topics and articles from the week and make it easy on you.

4 Tips for Managing a New Medical Sales Territory

2 years ago

A number of sales reps think sales success happens because you can schmooze and are a likable person. There is no doubt those factors can lead to one-off successes, but long-term success in sales in due to strategy and planning.

Muddy Waters Research still coming for St. Jude Medical

2 years ago

Short seller, Muddy Waters Research, and St. Jude Medical are back at it this week in what's becoming a modern day corporate pissing match. Despite being sued by St. Jude for making "false statements, false advertising, conspiracy and manipulation of

Is Your Employee Ready to Be a Manager?

2 years ago

You have an ambitious team member who’s asking to be promoted to manager. He’s great at his job, but is he really ready to lead? How do you judge his skills and experience? What’s the best way to measure his potential?

Merck Oncology Overview

2 years ago

Earlier this week, Merck provided an update to investors on their strategy in Oncology and a review of the data presented at ESMO. The global launch strategy of KEYTRUDA across several tumor types is reviewed as well.

Mazor Robotics Reports Record System Purchase Orders

2 years ago

Mazor Robotics made a splash today when they announced the company received purchase orders for 25 systems during the third quarter, including pre-orders for the Mazor X, which is scheduled to launch later this month at the North American Spine Society

Stryker still going after ex-rep, despite bankruptcy

2 years ago

Ex-Stryker rep, Chris Ridgeway, has been in the middle of a legal battle with Stryker since September 2013 when they fired and sued him, claiming he conspired with Biomet to steal Stryker's trade secrets, pricing, and obtain a distributorship deal through

The 10 Most Expensive Prescriptions of 2016

2 years ago

Healthcare startup, GoodRx, recently published their list of the most expensive prescriptions in the U.S. The data is gathered by using actual prices from a sample claims reported by pharmacies throughout the United States.

Every Manager Needs to Practice Two Types of Coaching

2 years ago

Performance reviews haven’t disappeared quite yet. “Despite all the buzz about abolishing formal performance reviews, the vast majority of organizations continue to employ traditional vehicles for sharing performance-related information,” reported

To Get More Feedback, Act More Coachable

2 years ago

It’s hard to say who dreads critical feedback more: the manager giving it or the person receiving it. As the receiver, it can be uncomfortable and stressful to hear that you’re not performing well. And the manager, knowing this, fears that the receiver

How to Give Feedback to People Who Cry, Yell, or Get Defensive

2 years ago

There’s no denying that performance review season can be a headache for managers. The process of writing reviews and delivering feedback takes a lot of time (especially if you do it thoughtfully) and can be particularly anxiety provoking

Loading...

Email Newsletter Subscription.

Don’t you think it’s about time your (day) job got a bit easier? Us too.

Register today and we’ll add you to our mailing list.

I am a